Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Design, synthesis, and preliminary cardioprotective effect evaluation of danshensu derivatives. [electronic resource] by
- Cui, Qingbin
- Chen, Yonghong
- Zhang, Mingjuan
- Shan, Luchen
- Sun, Yewei
- Yu, Pei
- Zhang, Gaoxiao
- Wang, Dingyuan
- Zhao, Zengchao
- Xu, Qian
- Xu, Benhong
- Wang, Yuqiang
Producer: 20150331
In:
Chemical biology & drug design vol. 84
Availability: No items available.
|
|
8.
|
|
|
9.
|
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells. [electronic resource] by
- Cui, Qingbin
- Cai, Chao-Yun
- Wang, Jing-Quan
- Zhang, Shuang
- Gupta, Pranav
- Ji, Ning
- Yang, Yuqi
- Dong, Xingduo
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Producer: 20200122
In:
International journal of molecular sciences vol. 20
Availability: No items available.
|
|
10.
|
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an [electronic resource] by
- Ji, Ning
- Yang, Yuqi
- Cai, Chao-Yun
- Wang, Jing-Quan
- Lei, Zi-Ning
- Wu, Zhuo-Xun
- Cui, Qingbin
- Yang, Dong-Hua
- Chen, Zhe-Sheng
- Kong, Dexin
Publication details: Frontiers in oncology 2019
In:
Frontiers in oncology vol. 9
Availability: No items available.
|
|
11.
|
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells. [electronic resource] by
- Wang, Jing-Quan
- Li, Jonathan Y
- Teng, Qiu-Xu
- Lei, Zi-Ning
- Ji, Ning
- Cui, Qingbin
- Zeng, Leli
- Pan, Yihang
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Publication details: Cancers Feb 2020
In:
Cancers vol. 12
Availability: No items available.
|
|
12.
|
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells. [electronic resource] by
- Cui, Qingbin
- Cai, Chao-Yun
- Gao, Hai-Ling
- Ren, Liang
- Ji, Ning
- Gupta, Pranav
- Yang, Yuqi
- Shukla, Suneet
- Ambudkar, Suresh V
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Publication details: Frontiers in oncology 2019
In:
Frontiers in oncology vol. 9
Availability: No items available.
|
|
13.
|
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells. [electronic resource] by
- Wang, Jingqiu
- Wang, Jing-Quan
- Cai, Chao-Yun
- Cui, Qingbin
- Yang, Yuqi
- Wu, Zhuo-Xun
- Dong, Xingduo
- Zeng, Leli
- Zhao, Linguo
- Yang, Dong-Hua
- Chen, Zhe-Sheng
Publication details: Frontiers in oncology 2020
In:
Frontiers in oncology vol. 10
Availability: No items available.
|
|
14.
|
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. [electronic resource] by
- Fan, Ying-Fang
- Zhang, Wei
- Zeng, Leli
- Lei, Zi-Ning
- Cai, Chao-Yun
- Gupta, Pranav
- Yang, Dong-Hua
- Cui, Qingbin
- Qin, Zuo-Dong
- Chen, Zhe-Sheng
- Trombetta, Louis D
Producer: 20190506
In:
Cancer letters vol. 421
Availability: No items available.
|
|
15.
|
A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells. [electronic resource] by
- Wang, Liang
- Zhang, Xiaojing
- Chan, Judy Yuet-Wa
- Shan, Luchen
- Cui, Guozhen
- Cui, Qingbin
- Wang, Yingfei
- Li, Jingjing
- Chen, Huanxian
- Zhang, Qingwen
- Yu, Pei
- Han, Yifan
- Wang, Yuqiang
- Lee, Simon Ming-Yuen
Producer: 20161213
In:
Journal of cellular biochemistry vol. 117
Availability: No items available.
|